A study evaluating the efficacy of administered maintenance treatments in bipolar disorder I and II.
Study identifier:NIS-NGR-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prospective, observational study for the maintenance treatment of patients with Bipolar Disorder I and II in Greece.
Medical condition
Bipolar Disorder
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
294
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Nov 2011
Study Completion Date: 01 Nov 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Outpatients with bipolar disorder I or II (as per DSM-IV) The percentage of patients who experience a relapse episode during the first 9 months after a mood event (manic or depressive). | - |
Contacts
Investigators
Principal Investigator
Dr. Panagiotis Pontikis
AstraZeneca S.A. Greece
